Hélène Haegel
Nessuna posizione attualmente
Profilo
Hélène Haegel was the founder of ElsaLys Biotech SAS, where she held the title of Head-Preclinical Biology Department until she became inactive.
The company was founded in 2013.
Precedenti posizioni note di Hélène Haegel
| Società | Posizione | Fine |
|---|---|---|
| ELSALYS BIOTECH | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Borsa valori
- Insiders
- Hélène Haegel
